text
"[""\n8. 핵심 연구인력 현황 - SK바이오팜\n☞ 본문 위치로 이동\n직위 (담당업무)\n성명\n대표논문\n주요 연구실적(국책과제, 학회발표, 대표특허)\nSAB 위원\n맹철영\nPapke et al (2014) The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors, is regulated by aromatic amino acids that span the subunit interface. J. Biol. Chem. 298:4515-4531.\nChi et al (2007) Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism. Proc. Natl. Acad. Sci. USA 104:9230-9235.\nMaeng et al (2001) Purification and structural analysis of the hepatitis B virus preS1 expressed from Eschericia coli. Biochem. Biophys. Re. Commun. 282:787-792.\nMaeng et al (1999) A novel HLA-DR12 allele (DRB1*1206) found in a Korean B-cell line. Tissue Antigens 53:516-518.\nStoops et al (1997) On the unique structural organization of the Saccharocymces cerevisiae pyruvate dehydrogenase complex. J. Biol. Chem. 272:5757-5764.\xa0\nMaeng et al (1996) Stoichiometry of binding of mature and truncated forms of the dihydrolipoamide dehydrogenase-binding protein to the dihydrolipoamide acetyltransferase core of the pyruvate dehydrogenase complex from Saccharomyces cerevisiae. Biochemistry 35:5879-5882.\nMaeng et al (1994) Expression, purification, and characterization of the dihydrolipoamide dehydrogenase-binding protein of the pyruvate dehydrogenase complex from Saccharomyces cerevisiae. Biochemistry 33:13801-13807.\n[학회발표]\nMaeng et al. In vitro pharmacological characterization and pro-cognitive effects of the novel alpha-7 nicotinic acetylcholine receptor partial agonist, SKL-A4R. Neuroscience 2011, Society of Neuroscience\n\xa0\n[대표특허]\nOxazole hydroxamic acid derivatives and use thereof (등록일: 2011-10-18)\nPharmaceutical composition comprising pyridone derivatives (등록일: 2014-05-06)\nImidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same (등록일: 2017-08-29)\n신약연구소장\n정구민\nLee et al (2010) Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5567-71\n\xa0\nHa et al (1998) Stereospecific ring expansion of β-lactams to γ-lactams with trimethylsilyldiazomethane. Tetrahedron Lett. 39 : 7541-7544\n\xa0 \xa0\n[국책과제] 협동연구 책임자\n과기부 21세기 프론티어 연구개발사업\xa0\n생체기능조절물질 개발사업\xa0\n당뇨병 치료제 후보물질 창출 과제\xa0\n\xa0\n[대표특허]\nBenzoyl piperidine compounds (등록일: 2004-08-03)\n3-substituted propanamine compounds\xa0\n(등록일: 2012-01-24)\nPiperidine compounds, pharmaceutical composition comprising the same and its use\xa0\n(등록일: 2014-02-04)\n신약개발사업부장\n박정신\nPark et al (2014) Serotonin transporter occupancy of SKL10406 in humans: comparison of pharmacokineticpharmacodynamic modeling methods for estimation of occupancy parameters, Translational and Clinical Pharmacology 2014, vol.22,no.2,pp. 83-91\xa0\n[수상실적]세노바메이트 개발 혁신신약 장영실상 수상 (2022년, 과학기술정보통신부 장관상)\n임상시험 발전 공로상 수상 (2021년 세계 임상시험의 날, 보건복지부장관 표창)\n[학회발표]\nDIA-NIFDS 공동심포지움 발표: Strategy on nonclinical development of CNS drugs (2019.8)대한약학회 발표: Global development and launch of anti-epileptic new drug (2022.10)\xa0\n신약연구부문장\n황선관\nHwang et al (2012) Anti-cancer activity of a novel small molecule compound that simultaneously activates p53 and inhibits NF-κB signaling. PLoS One. 2012;7(9):e44259.\xa0\n\xa0\nHwang et al (2012) Small molecule-based disruption of the Axin/β-catenin protein complex regulates mesenchymal stem cell differentiation. Cell Res. 2012 Jan;22(1):237-47.\xa0\n\xa0\nKim et al (2003) BRCA1 associates with human papillomavirus type 18 E2 and stimulates E2-dependent transcription. Biochem Biophys Res Commun. 2003 Jun 13;305(4):1008-16.\n\xa0\nHwang et al (2002) Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner. J Biol Chem. 2002 Jan 25;277(4):2923-30.\n\xa0\nLee et al (2002) Functional interaction between p/CAF and human papillomavirus E2 protein. J Biol Chem. 2002 Feb 22;277(8):6483-9.\n\xa0\nLee et al (2002) SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem. 2002 Jun 21;277(25):22330-7.\n[국책과제] 주관연구 책임자\n첨단의료기술개발 _ 신약 재창출을 통한 희귀 난치 질환인 레녹스-가스토 증후군 치료제 개발 (임상)\n(2019.01.01~2020.12.31, 과제번호 H18C0951)\n\xa0\n[학회발표]\nCho et al (2008) The Wnt Agonist, SKL2020 Inhibits Neointimal Hyperplasia but Facilitates Re-Endothelialization, When Treated with Rapamycin in Porcine Coronary Artery Stent Model. American Heart Association, Circulation. 2008;118:S_899\n\xa0\nChoi et al (2006) GST3beta-independent Activation of Wnt signaling and bone formation in mice by SKL2001, Keystone symposium (Abstract #127).\n\xa0\n[대표특허]\nIsoxazole Derivatives and Use thereof\n(등록일: 2011-03-29)\nPharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder using sodium phenylbutyrate (등록일: 2011-06-28)\nOxazole hydroxamic acid derivatives and use thereof\n(등록일: 2011-10-18)\n항암연구소장\n박숙경\nChen et al (2012) Synthesis and screening of novel vitamin E derivatives for anticancer functions. Eur J Med Chem 2012 Dec; 58:72-83\xa0\n\xa0\nTiwary et al (2010) Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis. PLOS one. 2010 Jul; 5(7): e11865\n\xa0\nPark et al (2010) Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling. Breast Cancer Res Treat 2010 Nov; 124(2) 361-75\n\xa0\nShun et al (2010) Downregulation of Epidermal Growth Factor Receptor expression contributes to alpha-TEA's proapoptotic effects in human ovarian cancer cell lines. J Oncol 2010; 2010:824571.\xa0\n\xa0\nLi et al (2010) α-TEA-induced death receptor dependent apoptosis involves activation of acid sphingomyelinase and elevated ceramide-enriched cell surface membranes. Cancer Cell Int 2010 Oct; 10:40.\n\xa0\nYu et al (2009) Anticancer actions of natural and synthetic vitamin E forms: RRR-alpha-tocopherol blocks the anticancer actions of gamma-tocopherol. Mol Nutr Food Res 2009 Dec; 53(12): 1573-81\n[국책과제]\n선도형 난치암 연구 사업단 참여기업 과제 책임자 (2016년 12월 ~ 2019년 11월)\n\xa0\n[학회발표]\xa0\nPark et al. (2014) Identification of a novel orally active cMET and RON tyrosine kinase inhibitor for the treatment of cMET and RON-activated tumors. 2014 International Convention of the Pharmaceutical Society of Korea, South Korea.\n\xa0\nPark et al (2010) Novel mechanism of gamma-tocotrienol-induced apoptosis in breast cancer cells: endoplasmic reticulum stress dependent increase in death receptor signaling pathways. The AACR 101st Annual Meeting 2010 in Washington, DC.\n\xa0\nPark et al (2008) Investigation of anticancer and anti-angiogenic activity of novel tocotrienol analogs. The 2008 AICR Annual Research Conference on Food, Nutrition and Cancer in Washington, D.C\n\xa0\n[대표특허]\xa0\nBicyclic Compound and Use thereof\n(등록일: 2021-09-07)\nProtein kinase inhibitors comprising a pyrrolopyridazine derivative\n(등록일: 2017-04-19)\nNovel amino-phenyl-sulfonyl-acetate derivatives and use thereof\n(등록일: 2016-07-13)\n""]"
